Jaume Pons

Jaume Pons is the current President and CEO at ALX Oncology. Jaume has extensive experience in the pharmaceutical industry, having served as SVP and CSO of Rinat (acquired by Pfizer) and as a scientist at Chiron and UC Berkeley. Jaume's experience and expertise have made him a valuable asset to ALX Oncology and they are leading the company to success.

Jaume Pons received their postdoc in protein engineering from the University of California, Berkeley. Jaume then went on to study at Universitat de Barcelona.

Some individuals on their team include Peter García - Chief Financial Officer, Athanasios Tsiatis - SVP, Clinical Development, and Jeanne Jew - Chief Business Officer.